Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel activators and small-molecule inhibitors of STAT3 in cancer
Lehe Yang, Shichong Lin, Lingyuan Xu, et al.
Cytokine & Growth Factor Reviews (2019) Vol. 49, pp. 10-22
Open Access | Times Cited: 111

Showing 26-50 of 111 citing articles:

Metabolic alterations mediated by STAT3 promotes drug persistence in CML
Sweta B. Patel, Travis Nemkov, Davide Stefanoni, et al.
Leukemia (2021) Vol. 35, Iss. 12, pp. 3371-3382
Open Access | Times Cited: 33
L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling
Marco Giordano, Alessandra Decio, Chiara Battistini, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 33
Safety, tolerability, pharmacokinetics and preliminary antitumour activity of an antisense oligonucleotide targeting STAT3 (danvatirsen) as monotherapy and in combination with durvalumab in Japanese patients with advanced solid malignancies: a phase 1 study
Tomohiro Nishina, Tomoko Fujita, Naoto Yoshizuka, et al.
BMJ Open (2022) Vol. 12, Iss. 10, pp. e055718-e055718
Open Access | Times Cited: 26
Proteomimetics of Natural Regulators of JAK–STAT Pathway: Novel Therapeutic Perspectives
Sara La Manna, Ilaria De Benedictis, Daniela Marasco
Frontiers in Molecular Biosciences (2022) Vol. 8
Open Access | Times Cited: 23
Circ-HSP90A expedites cell growth, stemness, and immune evasion in non-small cell lung cancer by regulating STAT3 signaling and PD-1/PD-L1 checkpoint
Jie Lei, Jianfei Zhu, Bengang Hui, et al.
Cancer Immunology Immunotherapy (2022) Vol. 72, Iss. 1, pp. 101-124
Closed Access | Times Cited: 23
Research progress of STAT3-based dual inhibitors for cancer therapy
Xiao-Juan Yang, Lu Xu, Yang Li, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 91, pp. 117382-117382
Closed Access | Times Cited: 13
DDR2/STAT3 Positive Feedback Loop Mediates the Immunosuppressive Microenvironment by Upregulating PD-L1 and Recruiting MDSCs in Oxaliplatin-Resistant HCC
Wenfeng Liu, Feng Zhang, Bing Quan, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 18, Iss. 4, pp. 101377-101377
Open Access | Times Cited: 5
Natural STAT3 inhibitors: A mini perspective
Zhuo Wang, Chunngai Hui, Yusheng Xie
Bioorganic Chemistry (2021) Vol. 115, pp. 105169-105169
Closed Access | Times Cited: 27
A chemical probe inhibitor targeting STAT1 restricts cancer stem cell traits and angiogenesis in colorectal cancer
Pei-Hsuan Chou, Cong-Kai Luo, Niaz Wali, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 20
MEX3C-Mediated Decay of SOCS3 mRNA Promotes JAK2/STAT3 Signaling to Facilitate Metastasis in Hepatocellular Carcinoma
Yunyun Xiao, Yue Li, Dongni Shi, et al.
Cancer Research (2022) Vol. 82, Iss. 22, pp. 4191-4205
Open Access | Times Cited: 19
Pomegranate-specific natural compounds as onco-preventive and onco-therapeutic compounds: Comparison with conventional drugs acting on the same molecular mechanisms
Md. Mominur Rahman, Md. Rezaul Islam, Shopnil Akash, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e18090-e18090
Open Access | Times Cited: 12
A large-scale transcriptional analysis reveals herb-derived ginsenoside F2 suppressing hepatocellular carcinoma via inhibiting STAT3
Xue Tan, Xiaofang Ma, Yifei Dai, et al.
Phytomedicine (2023) Vol. 120, pp. 155031-155031
Closed Access | Times Cited: 12
Targeting STAT3 potentiates CDK4/6 inhibitors therapy in head and neck squamous cell carcinoma
Lin Dong, Chao Liu, Haoyang Sun, et al.
Cancer Letters (2024) Vol. 593, pp. 216956-216956
Closed Access | Times Cited: 4
20(S)-Ginsenoside Rh2 induces apoptosis and autophagy in melanoma cells via suppressing Src/STAT3 signaling
Jun‐Kui Li, Xiaoli Jiang, Zhu Zhang, et al.
Journal of Ginseng Research (2024) Vol. 48, Iss. 6, pp. 559-569
Open Access | Times Cited: 4
Pyrimidine compounds BY4003 and BY4008 inhibit glioblastoma cells growth via modulating JAK3/STAT3 signaling pathway
Nisar Ahmad, Lixue Chen, Zixi Yuan, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 5, pp. e00431-e00431
Open Access | Times Cited: 4
Novel risk loci encompassing genes influencing STAT3, GPCR, and oxidative stress signaling are associated with co-morbid GERD and COPD
Ava C. Wilson, Alison Rocco, J.W. Chiles, et al.
PLoS Genetics (2025) Vol. 21, Iss. 2, pp. e1011531-e1011531
Open Access
STMN1 regulates the stemness of gastric cancer cells by binding to HN1L to activate the STAT3 signaling pathway
Chunyang Wei, Xing Zhang, Hao Li, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Cancer Stem Cell (CSC) Inhibitors in Oncology—A Promise for a Better Therapeutic Outcome: State of the Art and Future Perspectives
Prashant S. Kharkar
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 24, pp. 15279-15307
Closed Access | Times Cited: 32
The natural product trienomycin A is a STAT3 pathway inhibitor that exhibits potent in vitro and in vivo efficacy against pancreatic cancer
Q. He, Jiang‐Jiang Tang, Yao Liu, et al.
British Journal of Pharmacology (2021) Vol. 178, Iss. 12, pp. 2496-2515
Open Access | Times Cited: 24
Natural Product Alantolactone Targeting AKR1C1 Suppresses Cell Proliferation and Metastasis in Non-Small-Cell Lung Cancer
Zhiwen Fu, Shijun Li, Jinmei Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Blood transcriptome analysis suggests an indirect molecular association of early life adversities and adult social anxiety disorder by immune-related signal transduction
Susanne Edelmann, Ariane Wiegand, Thomas Hentrich, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 10
Natural STAT3 Inhibitors for Cancer Treatment: A Comprehensive Literature Review
Seyed Mahdi Zarezadeh, Amir Mohammad Sharafi, Gisou Erabi, et al.
Recent Patents on Anti-Cancer Drug Discovery (2023) Vol. 19, Iss. 4, pp. 403-502
Closed Access | Times Cited: 9
Targeting C21orf58 is a Novel Treatment Strategy of Hepatocellular Carcinoma by Disrupting the Formation of JAK2/C21orf58/STAT3 Complex
Hao Jiang, Yang Wang, Doudou Wen, et al.
Advanced Science (2024) Vol. 11, Iss. 15
Open Access | Times Cited: 3
Enhancing cancer therapy: The role of drug delivery systems in STAT3 inhibitor efficacy and safety
Kangning Wang, Kan Zhou, Nian‐Nian Zhong, et al.
Life Sciences (2024) Vol. 346, pp. 122635-122635
Closed Access | Times Cited: 3
SVIL promotes ovarian cancer progression and epithelial-mesenchymal transition under hypoxic conditions through the TGF-β/Smad pathway
Dongfang Dai, Congzhu Li, Hongping Xia, et al.
Gynecologic Oncology (2024) Vol. 190, pp. 167-178
Closed Access | Times Cited: 3

Scroll to top